[EN] HYBRID NECROPTOSIS INHIBITORS<br/>[FR] INHIBITEURS HYBRIDES DE LA NÉCROPTOSE
申请人:HARVARD COLLEGE
公开号:WO2014145022A1
公开(公告)日:2014-09-18
The present invention relates to heterocyclic compounds (e.g., compounds described by Formula (I)) and pharmaceutically acceptable salts thereof. The invention also features pharmaceutical compositions that include these compounds and their use in therapy for treating conditions in which necroptosis is likely to play a substantial role. The heterocyclic compounds described herein can also achieve improved activity and selectivity towards RIP1 and/or RIP3.
Métaaminophénols 4-substitués, leur procédé de préparation, leur utilisation pour la teinture des fibres kératiniques et les composés intermédiaires utilisés dans le procédé de préparation
申请人:L'OREAL
公开号:EP0591060B1
公开(公告)日:1996-12-18
HYBRID NECROPTOSIS INHIBITORS
申请人:PRESIDENT AND FELLOWS OF HARVARD COLLEGE
公开号:US20160024098A1
公开(公告)日:2016-01-28
The present invention relates to heterocyclic compounds (e.g., compounds described by Formula (I)) and pharmaceutically acceptable salts thereof. The invention also features pharmaceutical compositions that include these compounds and their use in therapy for treating conditions in which necroptosis is likely to play a substantial role. The heterocyclic compounds described herein can also achieve improved activity and selectivity towards RIP1 and/or RIP3.
A Simple, Fast and Chemoselective Method for the Preparation of Arylthiols